Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medivir Major Shareholding Notification 2021

Feb 17, 2021

3177_iss_2021-02-17_e5ae99b6-8d2b-4786-981b-95e80f16159a.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Issuer Medivir Aktiebolag

Holder

Avanza Bank Holding AB för Försäkringsaktiebolaget Avanza Pension

Instrument
Instrument Aktier
Before the transaction
Shares Data not given*
Voting rights Data not given*
Transaction
Reason for major shareholding notification New share issue
Date 16/02/2021
Limit for number of shares 10 %
Limit for number of votes 10 %
After the transaction
Quantity
Shares 4,257,213
Directly held voting rights 0
Indirectly held voting rights 4,257,213
Percentage
Directly held shares 8.1656 %
Directly held voting rights 0 %
Indirectly held voting rights 8.1656 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 8.1656 % 4,257,213
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled 1.2585 % 656,120
Total 9.4241 % 4,913,333

Group total holdings

Voting rights 4,913,333 Percentage of voting rights 9.4241

Notes (other relevant informations according to law)

Flaggning sker för passerat tröskelvärde beträffande det aggregerade innehavet. Aktierna, samt övriga instrument enligt LHF 4 kap, 2§ första stycket 1 och finansiella instrument enligt LHF 4 kap. 2§ första stycket 3 innehas av Försäkringsaktiebolaget Avanza Pension som är ett helägt dotterbolag till Avanza Bank Holding AB (publ). Det är försäkringskunder som via depåfullmakt innehar de aktuella aktierna. Innehavet är beräknat på 52 135 651 utestående aktier och röster.

Published

17/02/2021 15:47

Contact

Name Joakim Lomell Email [email protected]

*Source of information has chosen not to submit the data

CLOSE PRINT

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25